|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 317.20 SEK | -3.65% |
|
-2.64% | +2.06% |
| 05-08 | US FDA Extends Review Period for BioArctic's Co-developed Alzheimer's Therapy | MT |
| 05-08 | Futures point to negative opening for Stockholm Stock Exchange (update) | FW |
| Capitalization | 28.14B 3.02B 2.58B 2.36B 2.24B 4.14B 289B 4.18B 10.96B 137B 11.33B 11.1B 476B | P/E ratio 2026 * |
499x | P/E ratio 2027 * | 32.8x |
|---|---|---|---|---|---|
| Enterprise value | 27.62B 2.96B 2.53B 2.32B 2.19B 4.07B 284B 4.11B 10.75B 135B 11.12B 10.89B 468B | EV / Sales 2026 * |
22x | EV / Sales 2027 * | 14.7x |
| Free-Float |
48.06% | Yield 2026 * |
0.61% | Yield 2027 * | 0.3% |
Last Transcript: BioArctic AB
| 1 day | -3.55% | ||
| 1 week | -2.64% | ||
| Current month | -2.04% | ||
| 1 month | -4.63% | ||
| 3 months | -0.88% | ||
| 6 months | +17.83% | ||
| Current year | +2.06% |
| 1 week | 313.2 |  | 337 |
| 1 month | 302.8 | | 347.4 |
| Current year | 284 | | 364.4 |
| 1 year | 169.6 | | 364.4 |
| 3 years | 137.7 | | 392 |
| 5 years | 66.7 | | 392 |
| 10 years | 20.4 | | 392 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 31/12/2012 | |
| Director of Finance/CFO | 55 | 31/05/2023 | |
| Chief Tech/Sci/R&D Officer | 65 | 31/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 79 | 23/01/2003 | |
| Chairman | 77 | 27/01/2003 | |
Eugen Steiner
CHM | Chairman | 72 | 31/05/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.65% | -2.64% | +80.02% | +4.27% | 3.17B | |
| +0.27% | -2.47% | -16.97% | -16.79% | 43.3B | |
| +1.33% | +5.72% | +34.83% | +31.94% | 34.55B | |
| +0.83% | -1.55% | +246.06% | +460.22% | 30.65B | |
| +0.29% | -0.79% | +12.10% | -6.99% | 28.97B | |
| +1.05% | -2.28% | +27.24% | +25.20% | 27.29B | |
| -0.40% | +5.96% | - | - | 14.82B | |
| +0.05% | -3.92% | +111.82% | +4,012.38% | 13.51B | |
| +0.90% | +1.14% | +126.99% | +114.33% | 12.46B | |
| +1.16% | +0.78% | +5.45% | -1.33% | 12.13B | |
| Average | +0.22% | +1.53% | +69.73% | +513.69% | 22.08B | |
| Weighted average by Cap. | +0.64% | +1.76% | +60.75% | +342.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.25B 134M 115M 105M 99.54M 184M 12.87B 186M 488M 6.1B 504M 494M 21.21B | 1.81B 194M 165M 152M 144M 266M 18.56B 269M 703M 8.8B 727M 712M 30.58B |
| Net income | 258M 27.69M 23.62M 21.66M 20.5M 38M 2.65B 38.36M 100M 1.26B 104M 102M 4.37B | 847M 90.91M 77.54M 71.12M 67.32M 125M 8.7B 126M 330M 4.13B 341M 334M 14.34B |
| Net Debt | -526M -56.51M -48.2M -44.2M -41.84M -77.54M -5.41B -78.28M -205M -2.57B -212M -208M -8.91B | -1.51B -162M -139M -127M -120M -223M -15.54B -225M -589M -7.37B -609M -597M -25.62B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/05/26 | 317.20 kr | -3.65% | 166,519 |
| 11/05/26 | 329.20 kr | +3.65% | 223,561 |
| 08/05/26 | 317.60 kr | -4.34% | 282,085 |
| 07/05/26 | 332.00 kr | +0.36% | 153,132 |
| 06/05/26 | 330.80 kr | +1.53% | 125,674 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BIOA B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition